Top

Cancer Immunology, Immunotherapy

Published in:

01-09-1999 | ORIGINAL ARTICLE

Vascular endothelial growth factor in malignant pleural effusion associated with lung cancer

Authors: Hiroaki Yanagawa, Eiji Takeuchi, Yoshihiro Suzuki, Yasukazu Ohmoto, Hiroyasu Bando, Saburo Sone

Published in: Cancer Immunology, Immunotherapy | Issue 7/1999

Title: Vascular endothelial growth factor in malignant pleural effusion associated with lung cancer
Authors: Hiroaki Yanagawa
Eiji Takeuchi
Yoshihiro Suzuki
Yasukazu Ohmoto
Hiroyasu Bando
Saburo Sone
Publication date: 01-09-1999
Publisher: Springer-Verlag
Published in: Cancer Immunology, Immunotherapy / Issue 7/1999
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI: https://doi.org/10.1007/s002620050592

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 7/1999

In situ T cells in melanoma

Tumour escape from the immune response: the last hurdle for successful immunotherapy of cancer?

Complement-mediated lysis of cultured osteosarcoma cell lines using chimeric mouse/human TP-1 IgG1 and IgG3 antibodies

Signaling defects in T lymphocytes of patients with malignancy

Targeting unique tumor antigens and modulating the cytokine environment may improve immunotherapy for tumors with immune escape mechanisms

Tumor-induced immune dysfunction

Keynote webinar | Spotlight on antibody–drug conjugates in cancer